カテゴリー： 世界, 医療/バイオ, LP Information

世界の非外科的尿失禁治療市場予測 2023年-2029年

【英語タイトル】Global Non-Surgical Urinary Incontinence Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09784）・商品コード：LP23DC09784
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非外科的尿失禁治療市場」は、過去の販売実績から2022年の世界の非外科的尿失禁治療の総販売量を検討し、2023年から2029年の予測される非外科的尿失禁治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非外科的尿失禁治療の市場規模を掲載し、XXX百万米ドル規模の世界の非外科的尿失禁治療市場の詳細な分析を提供します。本インサイトレポートは、世界の非外科的尿失禁治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非外科的尿失禁治療市場における各社の独自のポジションをより深く理解するために、非外科的尿失禁治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非外科的尿失禁治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非外科的尿失禁治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非外科的尿失禁治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非外科的尿失禁治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非外科的尿失禁治療の世界主要メーカーとしては、Medtronic、 Boston Scientific Corporation、 Johnson & Johnson、 Cogentix Medical、 Coloplast Corp、 Ethicon、 InControl Medical、 Hollister Incorporated、 Atlantic Therapeutics、 ZSI Medical、 B. Braun Melsungen、 Teleflex Medical、 STORZ MEDICAL、 Lumenis、 NeoTractなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非外科的尿失禁治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非外科的尿失禁治療市場をセグメンテーションし、種類別 (バイオフィードバック、電気刺激、薬物療法、その他)、用途別 (病院、クリニック、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：バイオフィードバック、電気刺激、薬物療法、その他

・用途別区分：病院、クリニック、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非外科的尿失禁治療市場の10年間の市場状況・展望は？
・世界および地域別に見た非外科的尿失禁治療市場成長の要因は何か？
・非外科的尿失禁治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・非外科的尿失禁治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非外科的尿失禁治療の年間販売量2018-2029、地域別現状・将来分析
・非外科的尿失禁治療の種類別セグメント：バイオフィードバック、電気刺激、薬物療法、その他
・非外科的尿失禁治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非外科的尿失禁治療の用途別セグメント：病院、クリニック、その他
・非外科的尿失禁治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非外科的尿失禁治療市場
・企業別のグローバル非外科的尿失禁治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非外科的尿失禁治療の年間売上：2018-2023年の売上、市場シェア
・企業別の非外科的尿失禁治療販売価格
・主要企業の非外科的尿失禁治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非外科的尿失禁治療の地域別レビュー
・地域別の非外科的尿失禁治療市場規模2018-2023：年間販売量、売上
・主要国別の非外科的尿失禁治療市場規模2018-2023：年間販売量、売上
・南北アメリカの非外科的尿失禁治療販売の成長
・アジア太平洋の非外科的尿失禁治療販売の成長
・ヨーロッパの非外科的尿失禁治療販売の成長
・中東・アフリカの非外科的尿失禁治療販売の成長

南北アメリカ市場
・南北アメリカの国別の非外科的尿失禁治療販売量、売上（2018-2023）
・南北アメリカの非外科的尿失禁治療の種類別販売量
・南北アメリカの非外科的尿失禁治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非外科的尿失禁治療販売量、売上（2018-2023）
・アジア太平洋の非外科的尿失禁治療の種類別販売量
・アジア太平洋の非外科的尿失禁治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非外科的尿失禁治療販売量、売上（2018-2023）
・ヨーロッパの非外科的尿失禁治療の種類別販売量
・ヨーロッパの非外科的尿失禁治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非外科的尿失禁治療販売量、売上（2018-2023）
・中東・アフリカの非外科的尿失禁治療の種類別販売量
・中東・アフリカの非外科的尿失禁治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非外科的尿失禁治療の製造コスト構造分析
・非外科的尿失禁治療の製造プロセス分析
・非外科的尿失禁治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非外科的尿失禁治療の主要なグローバル販売業者
・非外科的尿失禁治療の主要なグローバル顧客

地域別の非外科的尿失禁治療市場予測レビュー
・地域別の非外科的尿失禁治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非外科的尿失禁治療の種類別市場規模予測
・非外科的尿失禁治療の用途別市場規模予測

主要企業分析
Medtronic、 Boston Scientific Corporation、 Johnson & Johnson、 Cogentix Medical、 Coloplast Corp、 Ethicon、 InControl Medical、 Hollister Incorporated、 Atlantic Therapeutics、 ZSI Medical、 B. Braun Melsungen、 Teleflex Medical、 STORZ MEDICAL、 Lumenis、 NeoTract
・企業情報
・非外科的尿失禁治療製品
・非外科的尿失禁治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Non-Surgical Urinary Incontinence Treatment market size is projected to grow from US$ 1489.9 million in 2022 to US$ 3475.5 million in 2029; it is expected to grow at a CAGR of 12.9% from 2023 to 2029.
United States market for Non-Surgical Urinary Incontinence Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Surgical Urinary Incontinence Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Surgical Urinary Incontinence Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Surgical Urinary Incontinence Treatment players cover Medtronic, Boston Scientific Corporation, Johnson & Johnson, Cogentix Medical, Coloplast Corp, Ethicon, InControl Medical, Hollister Incorporated and Atlantic Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Non-invasive urinary incontinence treatment options are available for people who experience urinary incontinence, which is the involuntary loss of urine. These treatments may be used alone or in combination with other therapies, depending on the type and severity of the incontinence.
LPI (LP Information)’ newest research report, the “Non-Surgical Urinary Incontinence Treatment Industry Forecast” looks at past sales and reviews total world Non-Surgical Urinary Incontinence Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Surgical Urinary Incontinence Treatment sales for 2023 through 2029. With Non-Surgical Urinary Incontinence Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Surgical Urinary Incontinence Treatment industry.
This Insight Report provides a comprehensive analysis of the global Non-Surgical Urinary Incontinence Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Surgical Urinary Incontinence Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Surgical Urinary Incontinence Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Surgical Urinary Incontinence Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Surgical Urinary Incontinence Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Surgical Urinary Incontinence Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Biofeedback
Electrical stimulation
Medications
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific Corporation
Johnson & Johnson
Cogentix Medical
Coloplast Corp
Ethicon
InControl Medical
Hollister Incorporated
Atlantic Therapeutics
ZSI Medical
B. Braun Melsungen
Teleflex Medical
STORZ MEDICAL
Lumenis
NeoTract
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Surgical Urinary Incontinence Treatment market?
What factors are driving Non-Surgical Urinary Incontinence Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Surgical Urinary Incontinence Treatment market opportunities vary by end market size?
How does Non-Surgical Urinary Incontinence Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Surgical Urinary Incontinence Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-Surgical Urinary Incontinence Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-Surgical Urinary Incontinence Treatment by Country/Region, 2018, 2022 & 2029
2.2 Non-Surgical Urinary Incontinence Treatment Segment by Type
2.2.1 Biofeedback
2.2.2 Electrical stimulation
2.2.3 Medications
2.2.4 Others
2.3 Non-Surgical Urinary Incontinence Treatment Sales by Type
2.3.1 Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Non-Surgical Urinary Incontinence Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-Surgical Urinary Incontinence Treatment Sale Price by Type (2018-2023)
2.4 Non-Surgical Urinary Incontinence Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Non-Surgical Urinary Incontinence Treatment Sales by Application
2.5.1 Global Non-Surgical Urinary Incontinence Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Non-Surgical Urinary Incontinence Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-Surgical Urinary Incontinence Treatment Sale Price by Application (2018-2023)
3 Global Non-Surgical Urinary Incontinence Treatment by Company
3.1 Global Non-Surgical Urinary Incontinence Treatment Breakdown Data by Company
3.1.1 Global Non-Surgical Urinary Incontinence Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Company (2018-2023)
3.2 Global Non-Surgical Urinary Incontinence Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Non-Surgical Urinary Incontinence Treatment Revenue by Company (2018-2023)
3.2.2 Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Non-Surgical Urinary Incontinence Treatment Sale Price by Company
3.4 Key Manufacturers Non-Surgical Urinary Incontinence Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Surgical Urinary Incontinence Treatment Product Location Distribution
3.4.2 Players Non-Surgical Urinary Incontinence Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Surgical Urinary Incontinence Treatment by Geographic Region
4.1 World Historic Non-Surgical Urinary Incontinence Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-Surgical Urinary Incontinence Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-Surgical Urinary Incontinence Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-Surgical Urinary Incontinence Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Non-Surgical Urinary Incontinence Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-Surgical Urinary Incontinence Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-Surgical Urinary Incontinence Treatment Sales Growth
4.4 APAC Non-Surgical Urinary Incontinence Treatment Sales Growth
4.5 Europe Non-Surgical Urinary Incontinence Treatment Sales Growth
4.6 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Growth
5 Americas
5.1 Americas Non-Surgical Urinary Incontinence Treatment Sales by Country
5.1.1 Americas Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023)
5.1.2 Americas Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023)
5.2 Americas Non-Surgical Urinary Incontinence Treatment Sales by Type
5.3 Americas Non-Surgical Urinary Incontinence Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Surgical Urinary Incontinence Treatment Sales by Region
6.1.1 APAC Non-Surgical Urinary Incontinence Treatment Sales by Region (2018-2023)
6.1.2 APAC Non-Surgical Urinary Incontinence Treatment Revenue by Region (2018-2023)
6.2 APAC Non-Surgical Urinary Incontinence Treatment Sales by Type
6.3 APAC Non-Surgical Urinary Incontinence Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Surgical Urinary Incontinence Treatment by Country
7.1.1 Europe Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023)
7.1.2 Europe Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023)
7.2 Europe Non-Surgical Urinary Incontinence Treatment Sales by Type
7.3 Europe Non-Surgical Urinary Incontinence Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Surgical Urinary Incontinence Treatment by Country
8.1.1 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Type
8.3 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Surgical Urinary Incontinence Treatment
10.3 Manufacturing Process Analysis of Non-Surgical Urinary Incontinence Treatment
10.4 Industry Chain Structure of Non-Surgical Urinary Incontinence Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Surgical Urinary Incontinence Treatment Distributors
11.3 Non-Surgical Urinary Incontinence Treatment Customer
12 World Forecast Review for Non-Surgical Urinary Incontinence Treatment by Geographic Region
12.1 Global Non-Surgical Urinary Incontinence Treatment Market Size Forecast by Region
12.1.1 Global Non-Surgical Urinary Incontinence Treatment Forecast by Region (2024-2029)
12.1.2 Global Non-Surgical Urinary Incontinence Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Surgical Urinary Incontinence Treatment Forecast by Type
12.7 Global Non-Surgical Urinary Incontinence Treatment Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.1.3 Medtronic Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.3.3 Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Cogentix Medical
13.4.1 Cogentix Medical Company Information
13.4.2 Cogentix Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.4.3 Cogentix Medical Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cogentix Medical Main Business Overview
13.4.5 Cogentix Medical Latest Developments
13.5 Coloplast Corp
13.5.1 Coloplast Corp Company Information
13.5.2 Coloplast Corp Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.5.3 Coloplast Corp Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Coloplast Corp Main Business Overview
13.5.5 Coloplast Corp Latest Developments
13.6 Ethicon
13.6.1 Ethicon Company Information
13.6.2 Ethicon Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.6.3 Ethicon Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ethicon Main Business Overview
13.6.5 Ethicon Latest Developments
13.7 InControl Medical
13.7.1 InControl Medical Company Information
13.7.2 InControl Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.7.3 InControl Medical Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 InControl Medical Main Business Overview
13.7.5 InControl Medical Latest Developments
13.8 Hollister Incorporated
13.8.1 Hollister Incorporated Company Information
13.8.2 Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.8.3 Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hollister Incorporated Main Business Overview
13.8.5 Hollister Incorporated Latest Developments
13.9 Atlantic Therapeutics
13.9.1 Atlantic Therapeutics Company Information
13.9.2 Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.9.3 Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Atlantic Therapeutics Main Business Overview
13.9.5 Atlantic Therapeutics Latest Developments
13.10 ZSI Medical
13.10.1 ZSI Medical Company Information
13.10.2 ZSI Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.10.3 ZSI Medical Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ZSI Medical Main Business Overview
13.10.5 ZSI Medical Latest Developments
13.11 B. Braun Melsungen
13.11.1 B. Braun Melsungen Company Information
13.11.2 B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.11.3 B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 B. Braun Melsungen Main Business Overview
13.11.5 B. Braun Melsungen Latest Developments
13.12 Teleflex Medical
13.12.1 Teleflex Medical Company Information
13.12.2 Teleflex Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.12.3 Teleflex Medical Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teleflex Medical Main Business Overview
13.12.5 Teleflex Medical Latest Developments
13.13 STORZ MEDICAL
13.13.1 STORZ MEDICAL Company Information
13.13.2 STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.13.3 STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 STORZ MEDICAL Main Business Overview
13.13.5 STORZ MEDICAL Latest Developments
13.14 Lumenis
13.14.1 Lumenis Company Information
13.14.2 Lumenis Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.14.3 Lumenis Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Lumenis Main Business Overview
13.14.5 Lumenis Latest Developments
13.15 NeoTract
13.15.1 NeoTract Company Information
13.15.2 NeoTract Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
13.15.3 NeoTract Non-Surgical Urinary Incontinence Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 NeoTract Main Business Overview
13.15.5 NeoTract Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-Surgical Urinary Incontinence Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-Surgical Urinary Incontinence Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Biofeedback
Table 4. Major Players of Electrical stimulation
Table 5. Major Players of Medications
Table 6. Major Players of Others
Table 7. Global Non-Surgical Urinary Incontinence Treatment Sales by Type (2018-2023) & (K Units)
Table 8. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
Table 9. Global Non-Surgical Urinary Incontinence Treatment Revenue by Type (2018-2023) & ($ million)
Table 10. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Type (2018-2023)
Table 11. Global Non-Surgical Urinary Incontinence Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Non-Surgical Urinary Incontinence Treatment Sales by Application (2018-2023) & (K Units)
Table 13. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2018-2023)
Table 14. Global Non-Surgical Urinary Incontinence Treatment Revenue by Application (2018-2023)
Table 15. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Application (2018-2023)
Table 16. Global Non-Surgical Urinary Incontinence Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Non-Surgical Urinary Incontinence Treatment Sales by Company (2018-2023) & (K Units)
Table 18. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Company (2018-2023)
Table 19. Global Non-Surgical Urinary Incontinence Treatment Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Company (2018-2023)
Table 21. Global Non-Surgical Urinary Incontinence Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Non-Surgical Urinary Incontinence Treatment Producing Area Distribution and Sales Area
Table 23. Players Non-Surgical Urinary Incontinence Treatment Products Offered
Table 24. Non-Surgical Urinary Incontinence Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Non-Surgical Urinary Incontinence Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share Geographic Region (2018-2023)
Table 29. Global Non-Surgical Urinary Incontinence Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Non-Surgical Urinary Incontinence Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country/Region (2018-2023)
Table 33. Global Non-Surgical Urinary Incontinence Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023) & (K Units)
Table 36. Americas Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country (2018-2023)
Table 37. Americas Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country (2018-2023)
Table 39. Americas Non-Surgical Urinary Incontinence Treatment Sales by Type (2018-2023) & (K Units)
Table 40. Americas Non-Surgical Urinary Incontinence Treatment Sales by Application (2018-2023) & (K Units)
Table 41. APAC Non-Surgical Urinary Incontinence Treatment Sales by Region (2018-2023) & (K Units)
Table 42. APAC Non-Surgical Urinary Incontinence Treatment Sales Market Share by Region (2018-2023)
Table 43. APAC Non-Surgical Urinary Incontinence Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Region (2018-2023)
Table 45. APAC Non-Surgical Urinary Incontinence Treatment Sales by Type (2018-2023) & (K Units)
Table 46. APAC Non-Surgical Urinary Incontinence Treatment Sales by Application (2018-2023) & (K Units)
Table 47. Europe Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023) & (K Units)
Table 48. Europe Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country (2018-2023)
Table 49. Europe Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country (2018-2023)
Table 51. Europe Non-Surgical Urinary Incontinence Treatment Sales by Type (2018-2023) & (K Units)
Table 52. Europe Non-Surgical Urinary Incontinence Treatment Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Non-Surgical Urinary Incontinence Treatment
Table 60. Key Market Challenges & Risks of Non-Surgical Urinary Incontinence Treatment
Table 61. Key Industry Trends of Non-Surgical Urinary Incontinence Treatment
Table 62. Non-Surgical Urinary Incontinence Treatment Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Non-Surgical Urinary Incontinence Treatment Distributors List
Table 65. Non-Surgical Urinary Incontinence Treatment Customer List
Table 66. Global Non-Surgical Urinary Incontinence Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Non-Surgical Urinary Incontinence Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Non-Surgical Urinary Incontinence Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Non-Surgical Urinary Incontinence Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Non-Surgical Urinary Incontinence Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Non-Surgical Urinary Incontinence Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Non-Surgical Urinary Incontinence Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Medtronic Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 81. Medtronic Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 82. Medtronic Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Medtronic Main Business
Table 84. Medtronic Latest Developments
Table 85. Boston Scientific Corporation Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 86. Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 87. Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Boston Scientific Corporation Main Business
Table 89. Boston Scientific Corporation Latest Developments
Table 90. Johnson & Johnson Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 92. Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Cogentix Medical Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Cogentix Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 97. Cogentix Medical Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cogentix Medical Main Business
Table 99. Cogentix Medical Latest Developments
Table 100. Coloplast Corp Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Coloplast Corp Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 102. Coloplast Corp Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Coloplast Corp Main Business
Table 104. Coloplast Corp Latest Developments
Table 105. Ethicon Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Ethicon Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 107. Ethicon Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Ethicon Main Business
Table 109. Ethicon Latest Developments
Table 110. InControl Medical Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. InControl Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 112. InControl Medical Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. InControl Medical Main Business
Table 114. InControl Medical Latest Developments
Table 115. Hollister Incorporated Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 117. Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Hollister Incorporated Main Business
Table 119. Hollister Incorporated Latest Developments
Table 120. Atlantic Therapeutics Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 122. Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Atlantic Therapeutics Main Business
Table 124. Atlantic Therapeutics Latest Developments
Table 125. ZSI Medical Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. ZSI Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 127. ZSI Medical Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. ZSI Medical Main Business
Table 129. ZSI Medical Latest Developments
Table 130. B. Braun Melsungen Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 132. B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. B. Braun Melsungen Main Business
Table 134. B. Braun Melsungen Latest Developments
Table 135. Teleflex Medical Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Teleflex Medical Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 137. Teleflex Medical Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Teleflex Medical Main Business
Table 139. Teleflex Medical Latest Developments
Table 140. STORZ MEDICAL Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 142. STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. STORZ MEDICAL Main Business
Table 144. STORZ MEDICAL Latest Developments
Table 145. Lumenis Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. Lumenis Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 147. Lumenis Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Lumenis Main Business
Table 149. Lumenis Latest Developments
Table 150. NeoTract Basic Information, Non-Surgical Urinary Incontinence Treatment Manufacturing Base, Sales Area and Its Competitors
Table 151. NeoTract Non-Surgical Urinary Incontinence Treatment Product Portfolios and Specifications
Table 152. NeoTract Non-Surgical Urinary Incontinence Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. NeoTract Main Business
Table 154. NeoTract Latest Developments
List of Figures
Figure 1. Picture of Non-Surgical Urinary Incontinence Treatment
Figure 2. Non-Surgical Urinary Incontinence Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Surgical Urinary Incontinence Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-Surgical Urinary Incontinence Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-Surgical Urinary Incontinence Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Biofeedback
Figure 10. Product Picture of Electrical stimulation
Figure 11. Product Picture of Medications
Figure 12. Product Picture of Others
Figure 13. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type in 2022
Figure 14. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Type (2018-2023)
Figure 15. Non-Surgical Urinary Incontinence Treatment Consumed in Hospital
Figure 16. Global Non-Surgical Urinary Incontinence Treatment Market: Hospital (2018-2023) & (K Units)
Figure 17. Non-Surgical Urinary Incontinence Treatment Consumed in Clinic
Figure 18. Global Non-Surgical Urinary Incontinence Treatment Market: Clinic (2018-2023) & (K Units)
Figure 19. Non-Surgical Urinary Incontinence Treatment Consumed in Others
Figure 20. Global Non-Surgical Urinary Incontinence Treatment Market: Others (2018-2023) & (K Units)
Figure 21. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2022)
Figure 22. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Application in 2022
Figure 23. Non-Surgical Urinary Incontinence Treatment Sales Market by Company in 2022 (K Units)
Figure 24. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Company in 2022
Figure 25. Non-Surgical Urinary Incontinence Treatment Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Company in 2022
Figure 27. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Non-Surgical Urinary Incontinence Treatment Sales 2018-2023 (K Units)
Figure 30. Americas Non-Surgical Urinary Incontinence Treatment Revenue 2018-2023 ($ Millions)
Figure 31. APAC Non-Surgical Urinary Incontinence Treatment Sales 2018-2023 (K Units)
Figure 32. APAC Non-Surgical Urinary Incontinence Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Europe Non-Surgical Urinary Incontinence Treatment Sales 2018-2023 (K Units)
Figure 34. Europe Non-Surgical Urinary Incontinence Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue 2018-2023 ($ Millions)
Figure 37. Americas Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country in 2022
Figure 38. Americas Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country in 2022
Figure 39. Americas Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
Figure 40. Americas Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2018-2023)
Figure 41. United States Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Non-Surgical Urinary Incontinence Treatment Sales Market Share by Region in 2022
Figure 46. APAC Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Regions in 2022
Figure 47. APAC Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
Figure 48. APAC Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2018-2023)
Figure 49. China Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country in 2022
Figure 57. Europe Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country in 2022
Figure 58. Europe Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
Figure 59. Europe Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2018-2023)
Figure 60. Germany Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Market Share by Application (2018-2023)
Figure 69. Egypt Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Non-Surgical Urinary Incontinence Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-Surgical Urinary Incontinence Treatment in 2022
Figure 75. Manufacturing Process Analysis of Non-Surgical Urinary Incontinence Treatment
Figure 76. Industry Chain Structure of Non-Surgical Urinary Incontinence Treatment
Figure 77. Channels of Distribution
Figure 78. Global Non-Surgical Urinary Incontinence Treatment Sales Market Forecast by Region (2024-2029)
Figure 79. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Non-Surgical Urinary Incontinence Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Non-Surgical Urinary Incontinence Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非外科的尿失禁治療市場予測 2023年-2029年] (コード：LP23DC09784)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非外科的尿失禁治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腹圧性尿失禁用ペッサリー市場2022年：失禁リングペッサリー、サポート付きリングペッサリー、失禁ディッシュ、その他
  • 世界の尿石管理装置市場予測 2023年-2029年
  • 世界の腹圧性尿失禁用治療薬市場予測 2023年-2029年
  • 世界の外科用靴カバー市場予測 2023年-2029年
  • 世界の電動外科用ステープラー市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆